PSI Company Ltd.   Report issue

For profit
Founded: Ansan Korea, Republic of (1977)
Status: Defunct (2015)

Organization Overview

First Clinical Trial
2010
NCT01196208
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (1)

brentuximab vedotin (adcetris) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1